NRG BN002: Phase I study of checkpoint inhibitors anti-CTLA-4, anti-PD-1, the combination in patients with newly diagnosed glioblastoma. Article

cited authors

  • Sloan, Andrew E; Gilbert, Mark R; Zhang, Peixin; Aldape, Kenneth D; Wu, Jing; Rogers, Lisa R; Wen, Patrick Y; Barani, Igor J; Iwamoto, Fabio Massaiti; Raval, Raju R; Voloschin, Alfredo Daniel; De Groot, John Frederick; Won, Minhee; Mehta, Minesh P

fiu authors

publication date

  • May 20, 2018

Digital Object Identifier (DOI)

start page

  • 2053

end page

  • 2053


  • 36


  • 15_suppl